Ocular changes in β-thalassemia

Annals of Ophthalmology - Glaucoma

Volumn 30, Issue 6, 1998, Pages 357-360

  Gaba, Anu ^a,b   D'Souza, P ^b   Chandra, Jagdish ^b   Narayan, Shashi ^b   Sen, S ^c  

^a C 2A/254 B Janak Puri ^*  (India)

^b LHMC and Associated Hospitals   (India)

^c Charak Palika Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CATARACT; CHILD; CONTROLLED STUDY; FERRITIN BLOOD LEVEL; HUMAN; INFANT; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; PIGMENT DISORDER; PRIORITY JOURNAL; RETINA EDEMA; RETINA HEMORRHAGE;

EID: 0031733867     PISSN: 10794794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Weatherall DJ. The thalassemias. In: Williams WJ, Beuthler E, Erstev AJ, Lichtman MA, eds. Hematology. New York, NY: McGraw-Hill Publishing Co; 1991:510-539.
2. Olivieri NF, Buneic JR, Chew E, et al. Visual and auditory neurotoxicity in patients receiving subcutaneous desferrioxamine infusions. N Engl J Med. 1986;314(14):869-873.
3. Gartaganis S, Ismiridis K, Papageorgiou O, Beratis NG, Papanastasiou D. Ocular abnormalities in patients with β-thalassemia. Am J Ophthalmol. 1989;108(6):699-703.
4. Sorcinelli R, Sitzia H, Fiqu A, Lai Me. Ocular findings in β-thalassemia. Metab Pediatr Syst Ophthalmol. 1990;13(1):23-25.
5. Lakhanpal V, Schocket SS, Jiji R. Desferrioxamine (Desferal) induced toxic retinal pigmentary degeneration and presumed optic neuropathy. Ophthalmology. 1984;91:443.
6. Sen S. Epidemiology of thalassemia. Natl Thalassemia Bull. Feb. 9, 1993.
7. Tietz NW. Fundamentals of Clinical Chemistry. Philadelphia, Pa: WB Saunders Co; 1976:928.
8. Magli A, Fusco R, Mettivier V, Pisapia R. Ocular manifestations in thalassemia minor. Ophthalmology. 1982;184(3):139-146.
9. Davies SC, Marcus RE, Hungerford JL, Miller MH, Arden GB, Huehns ER. Ocular toxicity of high-dose intravenous desferrioxamine. Lancet. 1983;2(8343):181-184.
10. Borgnia-Pignatti C, De Stefano P, Broglia AM. Visual loss in patients on high-dose subcutaneous desferrioxamine. Lancet. 1984;1:681.
11. Cohen A, Martin M, Mizanin J, Konkle DF, Schwartz E. Vision and hearing during desferrioxamine therapy. J Pediatr. 1990;117:326-330.
12. Lederman HM, Cohen A, Lee JWW, Freedman MH, Gelfand EW. Desferrioxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood. 1984;64:748-753.
13. Kinsella FP, Mooney DJ. Angioid streaks in β-thalassemia minor. Br J Ophthalmol. 1988;72(4):303-304.